KRAS
G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma?
Transl Cancer Res
.
2023 Dec 31;12(12):3227-3232.
doi: 10.21037/tcr-23-1629.
Epub 2023 Nov 13.
Authors
Marie Muller
1
,
David Tougeron
2
Affiliations
1
Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Nancy, France.
2
Department of Hepatology and Gastroenterology, Poitiers University Hospital, Poitiers, France.
PMID:
38197074
PMCID:
PMC10774060
DOI:
10.21037/tcr-23-1629
No abstract available
Keywords:
KRAS G12C; adagrasib; cancer; sotorasib; targeted therapy.
Publication types
Editorial
Comment